Journal of Peking University (Health Sciences) ›› 2024, Vol. 56 ›› Issue (2): 284-292. doi: 10.19723/j.issn.1671-167X.2024.02.013
Previous Articles Next Articles
Zhanhong LAI1,Jiachen LI1,Zelin YUN1,Yonggang ZHANG2,Hao ZHANG3,Xiaoyan XING1,Miao SHAO1,Yuebo JIN1,Naidi WANG1,Yimin LI4,Yuhui LI1,*(),Zhanguo LI1,*()
CLC Number:
1 |
Tanboon J , Nishino I . Classification of idiopathic inflammatory myopathies: Pathology perspectives[J]. Curr Opin Neurol, 2019, 32 (5): 704- 714.
doi: 10.1097/WCO.0000000000000740 |
2 |
DeWane ME , Waldman R , Lu J . Dermatomyositis: Clinical features and pathogenesis[J]. J Am Acad Dermatol, 2020, 82 (2): 267- 281.
doi: 10.1016/j.jaad.2019.06.1309 |
3 | 罗澜, 邢晓燕, 肖云抒, 等. 抗合成酶综合征合并心脏受累患者的临床及免疫学特征[J]. 北京大学学报(医学版), 2021, 53 (6): 1078- 1082. |
4 |
Marco JL , Collins BF . Clinical manifestations and treatment of antisynthetase syndrome[J]. Best Pract Res Clin Rheumatol, 2020, 34 (4): 101503.
doi: 10.1016/j.berh.2020.101503 |
5 |
Pinal-Fernandez I , Casal-Dominguez M , Mammen AL . Immune-mediated necrotizing myopathy[J]. Curr Rheumatol Rep, 2018, 20 (4): 21.
doi: 10.1007/s11926-018-0732-6 |
6 |
Wolstencroft PW , Chung L , Li S , et al. Factors associated with clinical remission of skin disease in dermatomyositis[J]. JAMA Dermatol, 2018, 154 (1): 44- 51.
doi: 10.1001/jamadermatol.2017.3758 |
7 |
Lundberg IE , Fujimoto M , Vencovsky J , et al. Idiopathic inflammatory myopathies[J]. Nat Rev Dis Primers, 2021, 7 (1): 86.
doi: 10.1038/s41572-021-00321-x |
8 |
Bohan A , Peter JB . Polymyositis and dermatomyositis (first of two parts)[J]. N Engl J Med, 1975, 292 (7): 344- 347.
doi: 10.1056/NEJM197502132920706 |
9 |
Bohan A , Peter JB . Polymyositis and dermatomyositis (second of two parts)[J]. N Engl J Med, 1975, 292 (8): 403- 407.
doi: 10.1056/NEJM197502202920807 |
10 |
Lundberg IE , Tjärnlund A , Bottai M , et al. 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups[J]. Arthritis Rheumatol, 2017, 69 (12): 2271- 2282.
doi: 10.1002/art.40320 |
11 |
Allenbach Y , Mammen AL , Benveniste O , et al. 224th ENMC International Workshop: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016[J]. Neuromuscul Disord, 2018, 28 (1): 87- 99.
doi: 10.1016/j.nmd.2017.09.016 |
12 |
Oddis CV , Rider LG , Reed AM , et al. International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies[J]. Arthritis Rheum, 2005, 52 (9): 2607- 2615.
doi: 10.1002/art.21291 |
13 |
Aggarwal R , Rider LG , Ruperto N , et al. 2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative[J]. Ann Rheum Dis, 2017, 76 (5): 792- 801.
doi: 10.1136/annrheumdis-2017-211400 |
14 | Tiniakou E , Mecoli CA , Kelly W , et al. Anti-MDA5-positive dermatomyositis and remission in a single referral centre population[J]. Clin Exp Rheumatol, 2023, 41 (2): 309- 315. |
15 | Rider LG , Werth VP , Huber AM , et al. Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and patient/parent global activity, manual muscle testing (MMT), health assessment questionnaire (HAQ)/childhood health assessment questionnaire (C-HAQ), childhood myositis assessment scale (CMAS), myositis disease activity assessment tool (MDAAT), disease activity score (DAS), short form 36 (SF-36), child health questionnaire (CHQ), physician global damage, myositis damage index (MDI), quantitative muscle testing (QMT), myositis functional index-2 (FI-2), myositis activities profile (MAP), inclusion body myositis functional rating scale (IBMFRS), cutaneous dermatomyositis disease area and severity index (CDASI), cutaneous assessment tool (CAT), dermatomyositis skin severity index (DSSI), skindex, and dermatology life quality index (DLQI)[J]. Arthritis Care Res (Hoboken), 2011, 63 (Suppl 11): S118- S157. |
16 | Li Y , Li Y , Wu J , et al. Predictors of Poor Outcome of Anti-MDA5-associated rapidly progressive interstitial lung disease in a Chinese cohort with dermatomyositis[J]. J Immunol Res, 2020, 2020, 2024869. |
17 |
Sultan SM , Ioannou Y , Moss K , et al. Outcome in patients with idiopathic inflammatory myositis: Morbidity and mortality[J]. Rheumatology (Oxford), 2002, 41 (1): 22- 26.
doi: 10.1093/rheumatology/41.1.22 |
18 | Lee JS , Lee JE , Hong S , et al. Prognostic factors for steroid-free remission in patients with idiopathic inflammatory myopathies: Importance of anthropometric measurements[J]. Ther Adv Musculoskelet Dis, 2020, 12, 1759720x20936822. |
19 | Watanabe E , Gono T , Kuwana M , et al. Predictive factors for sustained remission with stratification by myositis-specific autoantibodies in adult polymyositis/dermatomyositis[J]. Rheumatology (Oxford), 2020, 59 (3): 586- 593. |
20 |
Mariampillai K , Granger B , Amelin D , et al. Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoanti-bodies[J]. JAMA Neurol, 2018, 75 (12): 1528- 1537.
doi: 10.1001/jamaneurol.2018.2598 |
21 |
Watanabe Y , Uruha A , Suzuki S , et al. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy[J]. J Neurol Neurosurg Psychiatry, 2016, 87 (10): 1038- 1044.
doi: 10.1136/jnnp-2016-313166 |
22 |
Merlonghi G , Antonini G , Garibaldi M . Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge[J]. Autoimmun Rev, 2022, 21 (2): 102993.
doi: 10.1016/j.autrev.2021.102993 |
23 | 杨红霞, 田小兰, 江薇, 等. 免疫介导坏死性肌病的临床和病理特征分析[J]. 北京大学学报(医学版), 2019, 51 (6): 989- 995. |
24 | Tiniakou E , Pinal-Fernandez I , Lloyd TE , et al. More severe disease and slower recovery in younger patients with anti-3-hydro-xy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy[J]. Rheumatology (Oxford), 2017, 56 (5): 787- 794. |
25 |
Day JA , Limaye V . Immune-mediated necrotising myopathy: A critical review of current concepts[J]. Semin Arthritis Rheum, 2019, 49 (3): 420- 429.
doi: 10.1016/j.semarthrit.2019.04.002 |
26 |
Redondo-Benito A , Curran A , Villar-Gomez A , et al. Opportunistic infections in patients with idiopathic inflammatory myopathies[J]. Int J Rheum Dis, 2018, 21 (2): 487- 496.
doi: 10.1111/1756-185X.13255 |
27 |
Sun S , Chen Z , Zhang D , et al. Description and analysis of a novel subtype of the anti-synthetase syndrome characterized by frequent attacks of fever and systemic inflammation in a single-center cohort study[J]. Front Immunol, 2021, 12, 729602.
doi: 10.3389/fimmu.2021.729602 |
28 |
Debray MP , Borie R , Revel MP , et al. Interstitial lung disease in anti-synthetase syndrome: Initial and follow-up CT findings[J]. Eur J Radiol, 2015, 84 (3): 516- 523.
doi: 10.1016/j.ejrad.2014.11.026 |
29 |
Hallowell RW , Ascherman DP , Danoff SK . Pulmonary manifestations of polymyositis/dermatomyositis[J]. Semin Respir Crit Care Med, 2014, 35 (2): 239- 248.
doi: 10.1055/s-0034-1371528 |
30 |
李玉慧, 姚海红, 张学武, 等. 94例皮肌炎患者器官受累及免疫学特征分析[J]. 北京大学学报(医学版), 2010, 42 (2): 140- 142.
doi: 10.3969/j.issn.1671-167X.2010.02.005 |
31 |
Johnson C , Pinal-Fernandez I , Parikh R , et al. Assessment of mortality in autoimmune myositis with and without associated interstitial lung disease[J]. Lung, 2016, 194 (5): 733- 737.
doi: 10.1007/s00408-016-9896-x |
32 |
Chen IJ , Wu YJJ , Lin CW , et al. Interstitial lung disease in polymyositis and dermatomyositis[J]. Clin Rheumatol, 2009, 28 (6): 639- 646.
doi: 10.1007/s10067-009-1110-6 |
33 |
Hallowell RW , Danoff SK . Diagnosis and management of myositis-associated lung disease[J]. Chest, 2023, 163 (6): 1476- 1491.
doi: 10.1016/j.chest.2023.01.031 |
34 |
Li L , Wang H , Wang Q , et al. Myositis-specific autoantibodies in dermatomyositis/polymyositis with interstitial lung disease[J]. J Neurol Sci, 2019, 397, 123- 128.
doi: 10.1016/j.jns.2018.12.040 |
35 |
Srivastava P , Dwivedi S , Misra R . Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis[J]. Rheumatol Int, 2016, 36 (7): 935- 943.
doi: 10.1007/s00296-016-3494-3 |
36 | Li Y , Gao X , Li Y , et al. Predictors and mortality of rapidly progressive interstitial lung disease in patients with idiopathic inflammatory myopathy: A series of 474 patients[J]. Front Med (Lausanne), 2020, 7, 363. |
37 |
Jiang W , Shi JL , Yang HX , et al. Long-term outcomes and prognosis factors in patients with idiopathic inflammatory myopathies based on myositis-specific autoantibodies: A single cohort study[J]. Arthritis Care Res (Hoboken), 2023, 75 (5): 1175- 1182.
doi: 10.1002/acr.24993 |
38 | Komac A , Gokcen N , Yazici A , et al. The role of lactate dehydrogenase-to-albumin ratio in clinical evaluation of adult-onset Still's disease[J]. Int J Clin Pract, 2021, 75 (10): e14615. |
39 |
Bohan A , Peter JB , Bowman RL , et al. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis[J]. Medicine (Baltimore), 1977, 56 (4): 255- 286.
doi: 10.1097/00005792-197707000-00001 |
40 | Tymms KE , Webb J . Dermatopolymyositis and other connective tissue diseases: A review of 105 cases[J]. J Rheumatol, 1985, 12 (6): 1140- 1148. |
41 | Niu Q , Zhao LQ , Ma WL , et al. A new predictive model for the prognosis of MDA5(+) DM-ILD[J]. Front Med (Lausanne), 2022, 9, 908365. |
42 | Ding Y , Ge Y . Anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis complicated with macrophage activation syndrome[J]. Ther Adv Chronic Dis, 2022, 13, 20406223221098128. |
43 |
Chen F , Wang D , Shu X , et al. Anti-MDA5 antibody is associa-ted with A/SIP and decreased T cells in peripheral blood and predicts poor prognosis of ILD in Chinese patients with dermatomyositis[J]. Rheumatol Int, 2012, 32 (12): 3909- 3915.
doi: 10.1007/s00296-011-2323-y |
44 | 朱冯赟智, 邢晓燕, 汤晓菲, 等. 肌炎合并血栓栓塞患者的临床及免疫学特征[J]. 北京大学学报(医学版), 2020, 52 (6): 995- 1000. |
45 |
Davalos D , Akassoglou K . Fibrinogen as a key regulator of inflammation in disease[J]. Semin Immunopathol, 2012, 34 (1): 43- 62.
doi: 10.1007/s00281-011-0290-8 |
[1] | Jinrong ZHU,Yana ZHAO,Wei HUANG,Weiwei ZHAO,Yue WANG,Song WANG,Chunyan SU. Clinical characteristics of COVID-19 infection in patients undergoing hemodialysis [J]. Journal of Peking University (Health Sciences), 2024, 56(2): 267-272. |
[2] | Xiaoqian SI,Xiujuan ZHAO,Fengxue ZHU,Tianbing WANG. Risk factors for acute respiratory distress syndrome in patients with traumatic hemorrhagic shock [J]. Journal of Peking University (Health Sciences), 2024, 56(2): 307-312. |
[3] | Yangyang LI,Lin HOU,Zijun MA,Shanyamei HUANG,Jie LIU,Chaomei ZENG,Jiong QIN. Association of pregnancy factors with cow's milk protein allergy in infants [J]. Journal of Peking University (Health Sciences), 2024, 56(1): 144-149. |
[4] | Xiaoqiang LIU,Yin ZHOU. Risk factors of perioperative hypertension in dental implant surgeries with bone augmentation [J]. Journal of Peking University (Health Sciences), 2024, 56(1): 93-98. |
[5] | Liang LUO,Yun LI,Hong-yan WANG,Xiao-hong XIANG,Jing ZHAO,Feng SUN,Xiao-ying ZHANG,Ru-lin JIA,Chun LI. Anti-endothelial cell antibodies in predicting early miscarriage [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 1039-1044. |
[6] | Wen-gen LI,Xiao-dong GU,Rui-qiang WENG,Su-dong LIU,Chao CHEN. Expression and clinical significance of plasma exosomal miR-34-5p and miR-142-3p in systemic sclerosis [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 1022-1027. |
[7] | Yu-fei LI,Ya-ni YAN,Jia-yang JIN,Chun LI,Qiu-yan PEI. Clinical characteristics of fetal cardiac disease in patients with anti-SSA antibody positive [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 1053-1057. |
[8] | Yan-hong MENG,Yi-fan CHEN,Pei-ru ZHOU. Clinical and immunological features of primary Sjögren's syndrome patients with positive anti-centromere protein B antibody [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 1088-1096. |
[9] | Qi WU,Yue-ming CAI,Juan HE,Wen-di HUANG,Qing-wen WANG. Correlation between dyslipidemia and rheumatoid arthritis associated interstitial lung disease [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 982-992. |
[10] | Hui WEI, Ci-dan-yang-zong, Yi-xi-la-mu, Bai-ma-yang-jin. Risk factors associated with different types of Henoch-Schönlein purpura in Tibetan patients at high altitude [J]. Journal of Peking University (Health Sciences), 2023, 55(5): 923-928. |
[11] | Wei ZHU,Bin ZHU,Xiao-guang LIU. Influential factors related to functional status after full-endoscopic lumbar discectomy [J]. Journal of Peking University (Health Sciences), 2023, 55(3): 537-542. |
[12] | Lu ZHANG,Cheng CHEN,Mei-ting WENG,Ai-ping ZHENG,Mei-ling SU,Qing-wen WANG,Yue-ming CAI. Characteristics of serum autoantibodies in patients with lupus nephritis and tubulointerstitial damage [J]. Journal of Peking University (Health Sciences), 2022, 54(6): 1094-1098. |
[13] | Xiao-yan XING,Jun-xiao ZHANG,Feng-yun-zhi ZHU,Yi-fan WANG,Xin-yao ZHOU,Yu-hui LI. Clinical analysis of 5 cases of dermatomyositis complicated with macrophage activation syndrome [J]. Journal of Peking University (Health Sciences), 2022, 54(6): 1214-1218. |
[14] | Zhe LIANG,Fang-fang FAN,Yan ZHANG,Xian-hui QIN,Jian-ping LI,Yong HUO. Rate and characteristics of H-type hypertension in Chinese hypertensive population and comparison with American population [J]. Journal of Peking University (Health Sciences), 2022, 54(5): 1028-1037. |
[15] | Jing QIAN,You-jia WEI,Yi-jing CHENG,Yi ZHANG,Bo PENG,Chun-mei ZHU. Analysis of clinical features and risk factors of necrotizing pneumonia in children [J]. Journal of Peking University (Health Sciences), 2022, 54(3): 541-547. |
|